Biodextris Inc. has a long history of providing reliable, flexible, high quality product development services in the vaccine field. As there are currently vigorous efforts to develop an effective COVID19 vaccine, we encourage you to contact us for help you may need in analytical method development, quality control testing, process development, protein characterization, production of high quality protein for GLP preclinical studies, reference standards, as well as the production and characterization of immunotools.
Client Satisfaction Survey conducted in October 2017Large Pharma, EuropeProject Leader
Don't change anything! Continue like this!
Very reactive and flexible. Very nice and efficient communication. Great !!!!
100% of the clients that completed our survey
- Were very satisfied with communication and exchange of information
- Would recommend Biodextris
- Rated the quality, the expertise of team and ability to meet project timelines as above average or outstanding
I had a very good experience working with the Biodextris team. I felt it was a collaborative effort where communication was open and suggestions, comments, and questions were welcome.Clinical-stage biopharmaceutical company, USHead of Non-Clinical Research
Biodextris is a valued partner, delivering results on-time and meeting our quality standards through a transparent and collaborative approach. They provide important and reliable supplementary support for advancement of our ongoing clinical programs.Biodextris CustomerProject Leader
Who is Biodextris?
Biodextris is comprised of experienced product development scientist located in Laval (Montreal), Quebec. The group has worked together since 2002, as part of ID Biomedical and later GSK-Vaccines. We have developed numerous products for all phases of clinical development for programs conducted in the US, Canada and Europe.
Our history leaves us with the know-how for high quality, robust, commercial product development combined with flexibility and the sense of urgency inherent in smaller organizations.
We look forward to sharing this expertise with you.